Perform Another (Advanced) Search

1.  Study Posting (1819) Trial #94539, Sickle Cell Disease, Cincinnati, OH
...be: • Five years of age or older with sickle cell anemia or sickle beta zero thalassemia OR • 15 years of age with sickle beta plus thalassemia or sickle hemoglobin C disease What is involved? Patients will complete a short questionnaire and ...
View Page

2.  Study Posting (77) Trial #153219, Iron Overload (Hemachromatosis), New Hyde Park, NY
...to participate in this study if you are: • Over 2 years of age • Diagnosed with thalassemia major, sickle cell disease low or intermediate (INT-1) risk MDS or other anemias and ...
View Page

3.  Study Posting (4519) Trial #100894, Anemia, Wroclaw, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

4.  Study Posting (4519) Trial #104213, Anemia, Warszawa, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

5.  Study Posting (4519) Trial #101691, Anemia, Rzeszow, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

6.  Study Posting (4519) Trial #99087, Anemia, Poznan, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

7.  Study Posting (4519) Trial #103793, Anemia, Oswiecim, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

8.  Study Posting (4519) Trial #103792, Anemia, Krosno, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

9.  Study Posting (4519) Trial #104472, Anemia, Grodzisk Mazowiecki, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

10.  Study Posting (4519) Trial #97809, Anemia, Gdansk, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

11.  Study Posting (4519) Trial #97802, Anemia, Bydgoszcz, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

12.  Study Posting (4519) Trial #100029, Anemia, Bialystok, Poland
...renal anemia; • regular, stable dialysis for >=3 months. Exclusion Criteria: • hemoglobinopathy (ie, sickle cell disease, thalassemia); • gastrointestinal bleeding requiring medication or transfusion; • hypertension causing interruption of epoetin treatment; • malignant disease (except ...
View Page

13.  Study Posting (4519) Trial #103672, Anemia, Vittorio Veneto, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

14.  Study Posting (4519) Trial #104746, Anemia, Vecchiazzano, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

15.  Study Posting (4519) Trial #104010, Anemia, Roma, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

16.  Study Posting (4519) Trial #102652, Anemia, Pordenone, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

17.  Study Posting (4519) Trial #99844, Anemia, Pisa, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

18.  Study Posting (4519) Trial #99817, Anemia, Pavia, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

19.  Study Posting (4519) Trial #104060, Anemia, Napoli, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page

20.  Study Posting (4519) Trial #100154, Anemia, Monza, Italy
...cancer; • any type of chemotherapy planned for >=9 weeks; • anemia. Exclusion Criteria: • iron-deficiency anemia; • thalassemia syndrome; • blood transfusion or treatment with any erythropoietic agent within 4 weeks before study; • women ...
View Page